Best Healthcare Technology Companies To Buy Right Now

Below is the verbatim transcript of Parikh's interview with CNBC-TV18.

Q: The Equity Linked Savings Schemes (ELSS) funds are the favoured investment option where tax saving is concerned. But, which is the best option to choose for, for an investor. Do you think that it is dividend reinvestment, dividend payout or do you think growth would possibly be the best option?

A: Out of the three options available dividend reinvestment is something that we would not advice purely because dividend reinvestment will get the reinvested units to have a lock-in period of three years. However, between the growth and dividend payout options it depends actually on the investor.

We would generally recommend growth option because that allows for long-term compounding of the returns. However, in certain cases where the investor needs liquidity before the lock-in period, a dividend payout option can work well for the investor because the dividends can mean liquidity coming out of the ELSS scheme before the lock-in period.

Top 5 Canadian Stocks To Own For 2015: Bendigo and Adelaide Bank Ltd (BXRBF)

Bendigo and Adelaide Bank Limited (the Bank) is engaged in the range of banking and other financial services, including retail banking, mortgage distribution through third-parties, business lending, margin lending, business banking and commercial finance, invoice discounting, funds management, treasury and foreign exchange services (including trade finance), superannuation, financial advisory and trustee services. In retail banking it derives income from the provision of first mortgage finance less interest paid to depositors; and fee income from the provision of banking services delivered through the Company-owned branch network and the interest and fee income from the Community Bank branch network. In third party banking it derives income and fees from the manufacture and processing of residential home loans. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Australia stocks enjoyed early Monday gains after an advance for commodities and U.S. stocks since the last session, with a relatively good reception for earnings. The S&P/ASX 200 (AU:XJO) improved by 0.4% to 5,376.30, with miners tracking gains in gold and copper. Rio Tinto Ltd. (AU:RIO) (RIO) added 1.3%, and Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) traded 1.1% higher, while gold miners Newcrest Mining Ltd. (AU:NCM) (NCMGF) and Kingsgate Consolidated Ltd. (AU:KCN) (KSKGF) rallied 2.2% and 4.7%, respectively. Banks rose after Wall Street shares climbed on Friday, with National Australia Bank Ltd. (AU:NAB) (NAUBF) up 1% and Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) adding 0.9%, though Commonwealth Bank of Australia (AU:CBA) (CBAUF) dropped 2.4% as it traded without rights to its latest dividend. Coal transport firm Aurizon Holdings Ltd. (AU:AZJ) (QRNNF) tacked on 2.1% as its fiscal first-half underlying profit increased 18%, though net profit f

Best Healthcare Technology Companies To Buy Right Now: Organovo Holdings Inc (ONVO)

Organovo Holdings, Inc. (Organovo), formerly Real Estate Restoration & Rental, Inc., incorporated in 2007, is a development-stage company. The Company has developed and is commercializing a platform technology for the generation of three-dimensional (3D) human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. On December 28, 2011, Real Estate Restoration and Rental, Inc.�� (RERR) entered into an Agreement and Plan of Merger, pursuant to which RERR merged with its, wholly owned subsidiary, Organovo (Merger Sub). On February 8, 2012, the Company merged with and into Organovo Acquisition Corp. (Acquisition Corp.), a wholly owned subsidiary of Organovo, with the Company surviving the merger as a wholly owned subsidiary of Organovo Holdings (the Merger). As a result of the Merger, Organovo acquired the business of Organovo, Inc.

The Company has collaborative research agreements with Pfizer, Inc. (Pfizer) and United Therapeutic Corporation (Unither). As of March 31, 2012, it has five federal grants, including Small Business Innovation Research grants and developed the NovoGen MMX Bioprinter (its first-generation 3D bioprinter). The Company is engaged in the development of specific 3D human tissues to aid Pfizer in discovery of therapies in two areas of interest. In addition, in October 2011, it entered into a research agreement with Unither to establish and conduct a research program to discover treatments for pulmonary hypertension using its NovoGen MMX Bioprinter technology. Additionally, under the research agreement with Unither, the Company granted Unither an option to acquire from the Company a worldwide, royalty-bearing license in certain intellectual property created under the research agreement solely for use in the treatment or prevention of pulmonary hypertension and all other lung diseases.

The Company�� NovoGen MMX Bioprinter is an automate! d device that enables the fabrication of three-dimensional (3D) living tissues comprised of mammalian cells. A custom graphic user interface (GUI) facilitates the 3D design and execution of scripts that direct precision movement of the dispensing heads to deposit cellular building blocks (bio-ink) or supporting hydrogel. The Company is using a third party manufacturer, Invetech Pty., of Melbourne, Australia, to manufacture its NovoGen MMX Bioprinter. Its bioprinting technology and surrounding intellectual property and commercial rights serve as a platform for product generation across multiple markets that employ cell- and tissue-based products and services.

The Company competes with Organogenesis, Advanced BioHealing, Tengion, Genzyme, HumaCyte and Cytograft Tissue Engineering.

Advisors' Opinion:

• [By Harry Boxer]

  HARRY:  It is.  More than 10 years, I visited 3-D systems and saw a demo, and it was like whoa.  They weren’t even public then.  Of late, SSYS (Stratasys), Proto Labs (PRLB), EX1; those are the four big ones in the industry.  There is a little buy-out tech company called Orvganovo (ONVO) that is now bio-printing organs for testing.

• [By Roberto Pedone]

  Organovo (ONVO) develops 3D bioprinting technology for creating functional human tissues on demand for research and medical applications. This stock closed up 2.5% to $5.98 in Tuesday's trading session.

  Tuesday's Range: $5.70-$6.07
  
  52-Week Range: $1.80-$8.50
  
  Thursday's Volume: 2.03 million
  
  Three-Month Average Volume: 2.82 million

  From a technical perspective, ONVO jumped higher here right off its 50-day moving average of $5.79 with decent upside volume. This move is starting to push shares of ONVO within range of triggering a near-term breakout trade. That trade will hit if ONVO manages to take out some near-term overhead resistance levels at $6.20 to $6.39 with high volume.

  Traders should now look for long-biased trades in ONVO as long as it's trending above some near-term support levels at $5.50 or at $5 and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.82 million shares. If that breakout triggers soon, then ONVO will set up to re-test or possibly take out its next major overhead resistance levels at $7.50 to its 52-week high at $8.50. Any high-volume move above $8.50 will then put its all-time high at $10.90 within range for shares of ONVO.

• [By Paul Ausick]

  A unique 3D printing stock is Organovo Holdings Inc. (NYSEMKT: ONVO). Shares are down more than 15% in 2014 after rising about 325% in 2013. The company is developing a 3D bioprinting technology that can create functional human tissues on demand for research and medical use. Organovo announced a first delivery of liver tissue in late January, well ahead of schedule, and the stock gained back some of its year-to-date losses. The company has been publicly traded for about a year and a half, and the stock hit a post-IPO high of $13.65 in November. It closed on Friday at $9.35. There is no price target on the stock, and the company is not expected to post positive earnings at least through 2015. In terms of market cap, though, Organovo ranks fourth among the publicly traded 3D printing companies with a market value of nearly $728 million.

• [By James E. Brumley]

  It's certainly not the way I would have likes for things to shake out with Organovo Holdings Inc. (NYSEMKT:ONVO), but I'm not going to complain - it's pointed in the right direction. More important, for anybody who's been wanting into an ONVO trade but wasn't sure where the right entry spot was, today's move is it, with just one little caveat.

Best Healthcare Technology Companies To Buy Right Now: OSL Holdings Inc (OSLH)

OSL Holdings Inc., formerly Red Rock Pictures, Inc., incorporated on November 22, 2004, is an integrated marketer and distributor of Products for the Office. The Company operates in the competitive office supply market as a virtual distributor, leveraging the existing logistical capabilities of its suppliers who provide for inventory logistics, distribution and delivery. OSL focuses on the development and or acquisition of technology, sales, marketing and customer service. On October 10, 2011, the Company acquired Office Supply Line, Inc.

OSL offers 65,000 items from 1,000 manufacturers. It provides technology products, traditional office products, office furniture, janitorial and break-room supplies and industrial products. By partnering with the wholesaler, it delivers any of these products from one of their strategically located 45 distribution centers providing same or next day delivery to more than 90% of the United States. It has a range of catalogs, which represents more than 27,000 different items.

Advisors' Opinion:

• [By Peter Graham]

  Earlier in the month, Petrotech Oil & Gas�� LegalizePot.us announced that along with with their already expanded cannabis and hemp production and distribution channels in the states of Washington and Colorado, it was continuing to expand their business model into Rhode Island with a 2500 square foot grow facility up to 50 plants, and 50 to 70 lbs. a month management agreement. Otherwise, investors should be aware that Petrotech Oil & Gas only announced its expansion into medical and recently legalized recreational marijuana back in mid-February plus the company also announced in late February that it would begin oil production soon. A quick look at Petrotech Oil & Gas�� financials reveals revenues of $5k (most recent reported quarter), zero, zero and zero for the past four reported quarters along with net losses of $667k (most recent reported quarter), $49k, $73k and $653k. At the end of last September, Petrotech Oil & Gas had no cash to cover $1,584k in current liabilities. Given those financials and the recent entry into marijuana, investors might want to contain their excitement and wait for some new financials to reflect the sudden change in direction.

  OSL Holdings Inc (OTCMKTS: OSLH) Joins the Marijuana Party

  Small cap OSL Holdings Inc develops or acquires business units with the purpose of collecting and transmitting real-time consumer and business sales data to facilitate the sale of data, manage electronic marketplaces, operate real-time loyalty rewards and transact with buyers in multiple channels. On Friday, OSL Holdings Inc sank 20.47% to $0.190 for a market cap of $36.38 million plus OSLH is down 5% over the past year and up 1,017.6% over the past five years according to Google Finance.

Best Healthcare Technology Companies To Buy Right Now: Colony Financial Inc (CLNY)

Colony Financial, Inc. is a real estate investment and finance company. The Company primarily acquires, originates and manages a diversified portfolio of real estate-related debt instruments. The Company focuses on acquiring, originating and managing commercial mortgage loans, which may be performing, sub-performing or non-performing loans (including loan-to-own strategies), and other commercial real estate-related debt investments. The Company is managed by Colony Financial Manager, LLC (the Manager) and an affiliate of the Company.

The Company also may acquire other real estate and real estate-related debt assets. The Company collectively refers to commercial mortgage loans, other commercial real estate-related debt investments, commercial mortgage-backed securities (CMBS), real estate owned (REO), properties and other real estate and real estate-related assets as its target assets.

Advisors' Opinion:

• [By Amanda Alix]

  For Wall Street types, single-family foreclosures can be bought cheaply and in bulk, then fixed up and rented. Companies like the Blackstone Group (NYSE: BX  ) and Colony Financial (NYSE: CLNY  ) have been very active in this market, with the former purchasing 16,000 homes just last year, and the latter ramping up its own portfolio to approximately 7,000. This new industry has also spawned fresh entrants from the REIT field, Silver Bay Realty (NYSE: SBY  ) and Altisource Residential, (NYSE: RESI  ) two trusts that were spun off earlier this year from parent companies Two Harbors Investment (NYSE: TWO  ) and Altisource Portfolio Solutions (NASDAQ: ASPS  ) , specifically to take advantage of the boom in the foreclosure-to-rental market.

• [By Amanda Alix]

  The investment-to-REIT model is alive and well
  Before the very end of last year, those involved in the single-family purchase and rental business were largely private equity groups�like the Blackstone Group (NYSE: BX  ) , Colony Financial (NYSE: CLNY  ) , and Oaktree Capital (NYSE: OAK  ) , which bought up distressed properties by the truckload.

• [By Amanda Alix]

  Is it risky to be putting so much money into an as-yet unproven business model? Some may think so, including investors. Noting the tumble in stock price that newbies like Silver Bay and American Residential have suffered recently, Colony Capital (NYSE: CLNY  ) chief Thomas Barrack postponed�the IPO of his new single-family rental company, Colony American Homes. Similarly, Public Storage (NYSE: PSA  ) has filed for an IPO, too, hoping to take its American Homes 4 Rent unit public -- at some unannounced, future date. In the meantime, American Homes can rely on its $500 million credit facility�with Wells Fargo, which may be bumped up to $1 billion if necessary.